Unknown

Dataset Information

0

Classifying Crohn's disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification.


ABSTRACT:

Background

A suitable disease classification is essential for individualized therapy in patients with Crohn's disease (CD). Although a potential mechanistic classification of colon-involving and non-colon-involving disease was suggested by recent genetic and microbiota studies, the clinical implication has seldom been investigated. We aimed to explore the association of this colonic-based classification with clinical outcomes in patients with CD compared with the Montreal classification.

Methods

This was a retrospective study of CD patients from a tertiary referral center. Patients were categorized into colon-involving and non-colon-involving disease, and according to the Montreal classification. Clinico-demographic data, medications, and surgeries were compared between the two classifications. The primary outcome was the need for major abdominal surgery.

Results

Of 934 patients, those with colonic involvement had an earlier median (interquartile range) age of onset [23.0 (17.0-30.0) versus 26.0 (19.0-35.0) years, p?=?0.001], higher frequency of perianal lesions (31.2% versus 14.5%, p?versus 14.5%, p?=?0.010), but lower frequency of stricture (B2) (16.3% versus 24.0%, p?=?0.005), than those with non-colon-involving disease. Colon-involving disease was a protective factor against major abdominal surgery [hazard ratio, 0.689; 95% confidence interval (CI), 0.481-0.985; p?=?0.041]. However, patients with colon-involving CD were more prone to steroids [odds ratio (OR), 1.793; 95% CI, 1.206-2.666; p?=?0.004] and azathioprine/6-mercaptopurine (AZA/6-MP) treatment (OR, 1.732; 95% CI, 1.103-2.719; p?=?0.017) than were patients with non-colon-involving disease. The Montreal classification was not predictive of surgery or steroids and AZA/6-MP treatment.

Conclusion

This study supports the rationale for disease classification based on the involvement of colon. This new classification of CD is a better predictor of clinical outcomes than the Montreal classification.

SUBMITTER: Lin SN 

PROVIDER: S-EPMC7720347 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Classifying Crohn's disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification.

Lin Si-Nan SN   Zheng Dan-Ping DP   Qiu Yun Y   Zhang Sheng-Hong SH   He Yao Y   Chen Bai-Li BL   Zeng Zhi-Rong ZR   Mao Ren R   Chen Min-Hu MH  

Therapeutic advances in gastroenterology 20201203


<h4>Background</h4>A suitable disease classification is essential for individualized therapy in patients with Crohn's disease (CD). Although a potential mechanistic classification of colon-involving and non-colon-involving disease was suggested by recent genetic and microbiota studies, the clinical implication has seldom been investigated. We aimed to explore the association of this colonic-based classification with clinical outcomes in patients with CD compared with the Montreal classification.  ...[more]

Similar Datasets

2014-12-31 | GSE53867 | GEO
| S-EPMC3630802 | biostudies-literature
| S-EPMC4130615 | biostudies-literature
| S-EPMC6409715 | biostudies-literature
| S-EPMC6857154 | biostudies-literature
| S-EPMC4732693 | biostudies-literature
2023-12-31 | GSE197088 | GEO
| S-EPMC10487382 | biostudies-literature
2016-05-28 | GSE82009 | GEO
2020-08-24 | GSE141553 | GEO